Home > Drug Search >
  • Targets: Inhibitor of apoptosis protein (IAP)
  •   > 
Drug Filter
Category:
chemistry (8) biology (36)
Status:
Approved (3) Withdrawn (1) Phase Ⅲ (2) Phase Ⅱ (13) Phase Ⅰ (24) IND Filing (1)
Clinical Stage:
Pending (2) Active (29) Discontinued (8)
Bio-Type:
Cell therapy (1) CAR T cell therapy (2) Bispecific antibody (20) Whole antibody (9) ADC (2) Fusion protein (1)
Company:
Genentech (1) Genmab (1) GlaxoSmithKline (2) Janssen (3) MedImmune (2) Millennium Pharmaceutical (1) National Cancer Institute (1) National Institutes of Health (1) Novartis (1) Pfizer (2) Regeneron Pharmaceutical (1) Roche (2) Sanofi (1) Seattle Genetics (1) Servier (2) Trion Research (1) Barbara Ann Karmanos Cancer Institute (1) Xencor (2) NovImmune (1) Brigham and Women's Hospital (1) bluebird bio (1) Baylor College of Medicine (2) Texas Children's Hospital (1) Methodist Hospital System (1) Medarex (2) AOP Orphan Pharmaceuticals (1) Affimed (2) Angimmune (1) Therapix (1) University of Texas M. D. Anderson Cancer Center (1) Immunocore (1) Micromet (1) TransTarget (1) Mirati Therapeutics (1) Glenmark Pharma (1) Tetralogic Pharmaceutical (1) Emergent (1) Curis (1) MacroGenics (6) Aslan (1) MorphoSys (1) Tiziana Life Sciences (1) Pharmascience (1) University of Louisville (1) Ajanta Pharma (1) Tolerx (1) Amgen (4) Bayer (1) Bristol-Myers Squibb (2) BTG plc (1) Chugai (1)
Indication:
Non-alcoholic steatohepatitis (1) Acute lymphoblastic leukaemia (ALL) (3) Acute myeloid Leukemia (AML) (3) Breast cancer (3) Chronic lymphocytic leukemia (CLL) (3) Crohn's disease (1) Cutaneous T cell lymphoma (CTCL) (1) ROS1-positive non-small cell lung cancer(NSCLC) (1) Transplant rejection (1) Follicular lymphoma (1) Gastric cancer (1) HBV infection (1) HCV infection (1) Lymphoma (3) Malignancies (1) Mantle cell lymphoma (MCL) (1) Melanoma (2) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (2) Myelofibrosis (1) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin B-cell lymphomas (1) Non-Hodgkin’s lymphoma (NHL) (4) Ovarian cancer (1) Prostate cancer (2) Rejection of organ transplantation (1) Solid tumours (10) Ulcerative colitis (1) Hodgkin lymphoma (7) Systemic anaplastic large cell lymphoma (1) Colorectal cancer (1) Malignant Ascites (1) T-cell lymphoblastic lymphoma (1) B-cell lymphoma (3) Type 1 diabetes (3) Lymphoblastic leukaemia (1) Diffuse large B cell lymphoma (1) hematological malignancies (2) Gastrointestinal cancer (1)
Aprv. Year:
1995 (1) 2011 (2) 2014 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top